Jazz Pharmaceuticals plc (JAZZ) Tuesday reported first-quarter net income of $43.4 million or $0.71 per share, up from $27.7 million or $0.48 per share last year.
Adjusted net income for the first quarter was $84.4 million or $1.37 per share, up from $51.7 million or $0.89 per share last year.
Total revenues for the quarter grew to $196.2 million from $102.5 million last year.
Analysts polled by Thomson Reuters estimated earnings of $1.35 per share on revenues of $189.82 million for the quarter. Analysts' estimates typically exclude special items.
The company lifted its earnings guidance for the full year 2013. The company now expects earnings of $3.32 to $3.69 per share, adjusted earnings of $6.10 to $6.30 per share and revenues of $830 million to $860 million.
Analysts currently estimate earnings of $5.87 per share on revenues of $825.48 million for the quarter.
Previously, the company expected earnings of $3.17 to $3.47 per share, adjusted earnings of $5.70 to $5.90 per share, and revenues of $805 million to $835 million.
For comments and feedback: editorial@rttnews.com